Tension and trauma releasing exercises for people with multiple sclerosis - An exploratory pilot study

10.1016/j.jtcme.2021.02.003

M. Lynning；C. Svane；K. Westergaard；S.O. Bergien；S.R. Gunnersen；L. Skovgaard

Mind-body therapies ； Outcome measures ； Symptom management ； Self-help therapy ； Tension release

Journal of Traditional and Complementary Medicine

11卷5期（2021 / 09 / 01）

383 - 389

英文

Background and aim: Multiple sclerosis (MS) is characterized by increasing symptom burden leading many people with MS to use complementary treatments. TRE (Tension and Trauma Releasing Exercises) is a mind-body therapeutic method aiming to release muscle tension and stress. People with MS (PwMS) have reported benefits from TRE, but no scientific studies have investigated the effects of TRE on PwMS. Aim: To test a TRE program for PwMS and thereby explore outcome measures to be applied in future randomized studies. Experimental procedure: A nine-week TRE program was completed by nine participants: Five were women, age ranged from 44 to 66 years, and time since diagnosis ranged from 2 to 21 years. Outcome measures included self-reported day-to-day levels of nine different symptoms as well as sleep quality and stress level. Modified Fatigue Impact Scale (MFIS) fatigue score and spasticity level of the ankle plantar flexors, assessed using a Portable Spasticity Assessment Device (PSAD), were measured pre and post intervention. Results: Decreases were seen in the mean scores of all nine self-reported day-to-day symptoms as well as stress level, while sleep quality mean score increased. LME analyses showed that all changes were statistically significant except one (bowel dysfunction). Mean MFIS-measured fatigue level decreased significantly from a score of 43.7 (SD = 13.6) to a score of 22.0 (SD = 12.3). No significant change was reported in PSAD-measured spasticity level. Conclusion: The study indicates possible effects of TRE on PwMS on several self-reported outcome measures. Larger, randomized studies should be carried out to explore the findings further.

1. Information NC for B, Pike USNL of M 8600 R, MD B, Usa 20894. National center for Biotechnology information. https://www.ncbi.nlm.nih.gov/. Accessed May 6, 2020.
2. Austrian-Military-Research-Project-Outline.pdf. http://traumaprevention.com/wp-content/uploads/2016/04/Austrian-Military-Research-Project-Outline.pdf. Accessed February 16, 2018.
3. VA-Research-Announcement.pdf. http://traumaprevention.com/wp-content/uploads/2016/04/VA-Research-Announcement.pdf. Accessed February 16, 2018.
4. Bankhead C, Aronson J, Nunan D. Attrition bias. Catalog of bias. Published July 20 https://catalogofbias.org/biases/attrition-bias/; 2017. Accessed July 9, 2020.
5. Barin, L,Salmen, A,Disanto, G(2018).The disease burden of Multiple Sclerosis from the individual and population perspective: which symptoms matter most?.Mult Scler Relat Disord,25,112-121.
6. Barnes, MP,Kent, RM,Semlyen, JK,McMullen, KM(2003).Spasticity in multiple sclerosis.Neurorehabilitation Neural Repair,17(1),66-70.
7. Berceli, D(2015).Shake it off naturally: reduce stress, anxiety and tension with (TRE).CreateSpace.
8. Berceli, D(2008).The Revolutionary Trauma Release Process.Namaste Pub.
9. Berceli, D,Salmon, M,Bonifas, R,Ndefo, N(2014).Effects of self-induced unclassified therapeutic tremors on quality of life among non-professional caregivers: a pilot study.Glob Adv Health Med,3(5),45-48.
10. Bøe Lunde, HM,Aae, TF,Indrevåg, W(2012).Poor sleep in patients with multiple sclerosis.PloS One,7(11),e49996.
11. Brassey J, Mahtani K, Spencer E, Heneghan C. Volunteer bias. Catalog of bias. Published November 17 https://catalogofbias.org/biases/volunteer-bias/; 2017. Accessed July 8, 2020.
12. Carrithers, MD(2014).Update on disease-modifying treatments for multiple sclerosis.Clin Therapeut,36(12),1938-1945.
13. Caruana, EJ,Roman, M,Hernández-Sánchez, J,Solli, P(2015).Longitudinal studies.J Thorac Dis,7(11),E537-E540.
14. Giacoppo, S,Bramanti, P,Mazzon, E(2017).Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation.Mult Scler Relat Disord,17,22-31.
15. Grandner, MA,Rosenberger, ME(2019).Actigraphic sleep tracking and wearables: historical context, scientific applications and guidelines, limitations, and considerations for commercial sleep devices.Sleep and Health
16. Hugos, CL,Cameron, MH(2019).Assessment and measurement of spasticity in MS: state of the evidence.Curr Neurol Neurosci Rep,19(10),79.
17. Karnoe, A(2019).Development and feasibility test of a scale for patient-reported outcome measures in multpile sclerosis.Multiple Sclerosis Journal,25,1031-1072.
18. Kesselring, J,Beer, S(2005).Symptomatic therapy and neurorehabilitation in multiple sclerosis.Lancet Neurol,4(10),643-652.
19. Kratz, AL,Alschuler, KN,Ehde, DM(2019).A randomized pragmatic trial of telephone-delivered cognitive behavioral-therapy, modafinil, and combination therapy of both for fatigue in multiple sclerosis: the design of the "COMBO-MS" trial.Contemp Clin Trials,84,105821.
20. Kratz, AL,Murphy, SL,Braley, TJ(2017).Ecological momentary assessment of pain, fatigue, depressive, and cognitive symptoms reveals significant daily variability in multiple sclerosis.Arch Phys Med Rehabil,98(11),2142-2150.
21. Kurtzke, JF(1983).Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).Neurology,33(11),1444-1444.
22. Larson, RD(2013).Psychometric properties of the modified fatigue impact scale.Int J MS Care.,15(1),15-20.
23. Malhotra, S,Pandyan, A,Day, C,Jones, P,Hermens, H(2009).Spasticity, an impairment that is poorly defined and poorly measured.Clin Rehabil,23(7),651-658.
24. Nunan D, Bankhead C, Aronson J. Selection bias. Catalog of bias. Published March 28 https://catalogofbias.org/biases/selection-bias/; 2017. Accessed July 8, 2020.
25. Nylander, A,Hafler, DA(2012).Multiple sclerosis.J Clin Invest,122(4),11801188.
26. Rizzo, MA,Hadjimichael, OC,Preiningerova, J,Vollmer, TL(2004).Prevalence and treatment of spasticity reported by multiple sclerosis patients.Mult Scler Houndmills Basingstoke Engl,10(5),589-595.
27. Senders, A,Wahbeh, H,Spain, R,Shinto, L(2012).Mind-body medicine for multiple sclerosis: a systematic review.Autoimmune Dis.,2012,1-12.
28. Skovgaard, L,Nicolajsen, PH,Pedersen, E(2012).Use of complementary and alternative medicine among people with multiple sclerosis in the nordic countries.Autoimmune Dis.,2012,1-13.
29. Spencer E, Brassey J, Mahtani K, Heneghan C. Wrong sample size bias. Catalog of Bias. Published July 20 https://catalogofbias.org/biases/wrong-sample-size-bias/; 2017. Accessed July 8, 2020.
30. Spencer E, Heneghan C. Compliance bias. Catalog of bias. Published May 24 https://catalogofbias.org/biases/compliance-bias/; 2018. Accessed July 8, 2020.
31. Yamaguchi, T,Hvass, Petersen, T,Kirk, H(2018).Spasticity in adults with cerebral palsy and multiple sclerosis measured by objective clinically applicable technique.Clin Neurophysiol,129(9),2010-2021.